These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19464399)

  • 21. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.
    Garcia-Rodriguez C; Levy R; Arndt JW; Forsyth CM; Razai A; Lou J; Geren I; Stevens RC; Marks JD
    Nat Biotechnol; 2007 Jan; 25(1):107-16. PubMed ID: 17173035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidic library screening for mapping antibody epitopes.
    Bessette PH; Hu X; Soh HT; Daugherty PS
    Anal Chem; 2007 Mar; 79(5):2174-8. PubMed ID: 17253874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotechnological applications for surface-engineered bacteria.
    Wernérus H; Ståhl S
    Biotechnol Appl Biochem; 2004 Dec; 40(Pt 3):209-28. PubMed ID: 15035661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
    Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
    J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of antibodies using bacterial surface display.
    Rockberg J; Löfblom J; Hjelm B; Uhlén M; Ståhl S
    Nat Methods; 2008 Dec; 5(12):1039-45. PubMed ID: 19029907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The beginning of the end of a long wait for a vaccine against cytomegalovirus.
    Griffiths P
    Rev Med Virol; 2009 May; 19(3):117-9. PubMed ID: 19388047
    [No Abstract]   [Full Text] [Related]  

  • 28. Method for generation of human hyperdiversified antibody fragment library.
    Mondon P; Souyris N; Douchy L; Crozet F; Bouayadi K; Kharrat H
    Biotechnol J; 2007 Jan; 2(1):76-82. PubMed ID: 17225253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
    Houimel M; Dellagi K
    Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The B-cell epitope of the monoclonal anti-factor VIII antibody ESH8 characterized by peptide array analysis.
    Albert T; Egler C; Jakuschev S; Schuldenzucker U; Schmitt A; Brokemper O; Zabe-Kühn M; Hoffmann D; Oldenburg J; Schwaab R
    Thromb Haemost; 2008 Mar; 99(3):634-7. PubMed ID: 18327416
    [No Abstract]   [Full Text] [Related]  

  • 31. Analytic Vaccinology: Antibody-Driven Design of a Human Cytomegalovirus Subunit Vaccine.
    Kabanova A; Lilleri D
    Methods Mol Biol; 2016; 1403():167-86. PubMed ID: 27076130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibody recognition of cyclic epitope peptides, together with their dimer and conjugated derivatives based on residues 9-22 of herpes simplex virus type 1 glycoprotein D.
    Jakab A; Schlosser G; Feijlbrief M; Welling-Wester S; Manea M; Vila-Perello M; Andreu D; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):683-92. PubMed ID: 19271736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability.
    Conley GP; Viswanathan M; Hou Y; Rank DL; Lindberg AP; Cramer SM; Ladner RC; Nixon AE; Chen J
    Biotechnol Bioeng; 2011 Nov; 108(11):2634-44. PubMed ID: 21618474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope mapping using ribosome display in a reconstituted cell-free protein synthesis system.
    Osada E; Shimizu Y; Akbar BK; Kanamori T; Ueda T
    J Biochem; 2009 May; 145(5):693-700. PubMed ID: 19228777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.